CDX2 expression as a predictive and prognostic biomarker of 5-FU response in cancer of unknown primary.
- DOI
- 10.1016/j.esmoop.2025.105515
- Published
- 2025 Aug
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2025.105515,
title = {CDX2 expression as a predictive and prognostic biomarker of 5-FU response in cancer of unknown primary.},
author = {Fuentes Bayne HE and Suleiman R and Eiring RA and McGarrah PW and Thome SD and Graham RP and Garcia JJ and Halfdanarson TR},
year = {2025},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2025.105515},
url = {https://doi.org/10.1016/j.esmoop.2025.105515}
}RIS
TY - JOUR TI - CDX2 expression as a predictive and prognostic biomarker of 5-FU response in cancer of unknown primary. AU - Fuentes Bayne HE AU - Suleiman R AU - Eiring RA AU - McGarrah PW AU - Thome SD AU - Graham RP AU - Garcia JJ AU - Halfdanarson TR PY - 2025 JO - ESMO open DO - 10.1016/j.esmoop.2025.105515 UR - https://doi.org/10.1016/j.esmoop.2025.105515 ER -
APA
HE, F. B., R, S., RA, E., PW, M., SD, T., RP, G., JJ, G., & TR, H. (2025). CDX2 expression as a predictive and prognostic biomarker of 5-FU response in cancer of unknown primary.. ESMO open. https://doi.org/10.1016/j.esmoop.2025.105515
Source records
- pubmed · retrieved 2026-09-25T14:59:37.836Z